Jason DeHart is a highly experienced professional who has held key leadership roles in various companies within the pharmaceutical and biotechnology industry. From their time as a Postdoctoral Fellow at different research institutes to their current position as Vice President, Head of Gene Therapy at Replay, Jason has demonstrated expertise in RNA vaccine programs, molecular virology, and infectious diseases. With a strong educational background in Experimental Pathology and Molecular Biology, Jason continues to drive innovation and success in their field.
March 1, 2024 - present
July 1, 2023
March, 2023
October, 2021